MRCP
CC icon

Maple Rock Capital Partners’s Chemours CC Stock Holding History

Maple Rock Capital Partners’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100,000
Closed -$2.21M – 22
2016
Q4 		$2.21M Sell
100,000
-850,000
-89% -$17.5M 0.74% 19
2016
Q3 		$15.2M Buy
+950,000
New +$10.8M 5.75% 7

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Maple Rock Capital Partners's CC Position: Q1 2017 in Review

Maple Rock Capital Partners sold out of Chemours (CC) in Q1 2017, closing a stake of 100,000 shares — an estimated $2.21M sold.

Maple Rock Capital Partners first reported a position in CC in Q3 2016 and held it in 2 quarters. The position peaked at $15.2M in Q3 2016. 459 funds tracked by Wall St. Rank hold CC as of Q1 2017.

  • Maple Rock Capital Partners reported no remaining Chemours position as of Q1 2017 after selling out during the quarter.
  • Maple Rock Capital Partners sold 100,000 Chemours shares in Q1 2017, an estimated $2.21M.
  • Maple Rock Capital Partners first reported a position in Chemours in Q3 2016 and held it in 2 quarters.
  • Maple Rock Capital Partners's Chemours position peaked at $15.2M in Q3 2016.
  • 459 funds tracked by Wall St. Rank held Chemours as of Q1 2017.

Based on Maple Rock Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.